Our Pipeline and Therapeutic Targets
Lifestyle Chronic Disease
Collaborators / Partners
In the News
This author has not yet filled in any details.
So far nogretsch has created 0 blog entries.
VLP Therapeutics Appoints Jacob Licht as Chief Operating Officer
VLP Therapeutics Announces Convertible Note Investment from TomyK Ltd. for Accelerating Cancer Vaccine Development
VLP Therapeutics Receives Notice of Allowance of Key U.S. composition of matter Patent for immune checkpoint PD-1/PD-L1/PD-L2 inserted alphavirus VLP
VLP Therapeutics Appoints Danai Brooks, Managing Partner of Glen Echo Capital, to Advisory Board
VLP Therapeutics was featured in a TV program (January 5, 2017)